Due to our long-standing track record, we have been entrusted with numerous agency operations.
BioBridge Co., Ltd. has been expanding its transactions with high-quality pharmaceutical raw material manufacturers and contract laboratories, primarily in Europe and including Asia, since its establishment. We are also engaged in transactions with domestic pharmaceutical and chemical companies. We handle a wide range of products, from antibiotic raw material intermediates to generic active pharmaceutical ingredients, and radioactive isotopes (14C, 3H). 【Business Activities】 ■ Sales of pharmaceutical raw materials, radioactive isotopes, and chemicals ■ Liaison office and agency services for overseas pharmaceutical companies, testing and inspection organizations, and contract manufacturing companies ■ Application services for registration of pharmaceutical raw materials, among others *For more details, please download the PDF or feel free to contact us.
Inquire About This Product
basic information
【Pharmaceutical Affairs Support】 ■ Registration of Master Files ■ Support for Foreign Manufacturer Certification ■ Support for GMP Compliance Inspections ■ On-site Inspection Support for Manufacturers and Distributors *For more details, please download the PDF or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please download the PDF or feel free to contact us.
Company information
BioBridge Co., Ltd. is engaged in the import and sale of pharmaceutical raw material intermediates, the import and sale of specialty fine chemicals from domestic companies, the synthesis of radiolabeled compounds for pharmaceuticals and pesticides in the development stage, and the contracting of early exploratory clinical trials and consulting in the UK. We provide a wide range of regulatory support, including foreign manufacturer certification related to pharmaceutical imports, master file registration and maintenance, and GMP compliance investigations. Moving forward, our team of specialized experts will continue to offer a wide range of services, from supporting new drug development to providing imported generic pharmaceuticals.